Evidence map›Paper›PMID 31042729›Full record

ArticlePloS one2019

Impact of HIV-1 infection on the IGF-1 axis and angiogenic factors in pregnant Cameroonian women receiving antiretroviral therapy.

Livo F Esemu, Emile K Yuosembom, Rui Fang, Shayne Rasay, Barriere A Y Fodjo, John T Nguasong, Winifrida Kidima, Gabriel L Ekali, John J Chen, Lishomwa Ndhlovu and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Livo F EsemuThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.ORCID 0000-0002-0793-2826
Emile K YuosembomThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Rui FangBiostatistics Core, Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Shayne RasayDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Barriere A Y FodjoThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
John T NguasongThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Winifrida KidimaDepartment of Zoology, College of Natural and Applied Sciences, University of Dar es Salaam, Dar es Salaam, Tanzania.
Gabriel L EkaliThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
John J ChenBiostatistics Core, Department of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Lishomwa NdhlovuDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Jude D BigogaThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Diane W TaylorDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Rose G F LekeThe Biotechnology Center, University of Yaoundé I, Yaoundé, Cameroon.
Anna BabakhanyanDepartment of Tropical Medicine, Medical Microbiology and Pharmacology, University of Hawaii at Manoa, John A. Burns School of Medicine, Honolulu, Hawaii, United States of America.
Université de Yaoundé I · CMUniversity of Hawaiʻi at Mānoa · USUniversity of Dar es Salaam · TZ

Funding

The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Benjamin C. Fogelgren · 2017 to 2026
$59.5M
RESEARCH DESIGN AND BIOSTATISTICS COREU54MD007584 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI HEDGES, JERRIS ROBERT, MOKUAU, NOREEN · 2012 to 2018
$21.1M
NPGH LEADERs YR12: OBSSR (Greenberg, Ngwafong Mukere) & NIBIB (Lee)D43TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI Dibyadyuti Datta, Chandy C. John · 2017 to 2026
$15.2M
Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
Transdisciplinary Health Disparities Research Training for Native Hawaiians and Pacific StudentsT37MD008636 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI KAHOLOKULA, JOSEPH KEAWE'AIMOKU, SY, ANGELA U · 2014 to 2025
$2.7M
Training of Cameroonian Scientists in Research on MalariaD43TW009074 · FIC · UNIVERSITY OF HAWAII AT MANOA · PI NERURKAR, VIVEK RAMCHANDRA · 2011 to 2015
$978k
TRAINING OF CAMEROONIAN SCIENTISTSD43TW001264 · FIC · GEORGETOWN UNIVERSITY · PI TAYLOR, DIANE WALLACE · 1999 to 2003
$783k
FIC NIH HHS D43 TW001264FIC NIH HHS D43 TW009074FIC NIH HHS D43 TW009345FIC NIH HHS R25 TW009345NIMHD NIH HHS T37 MD008636NIMHD NIH HHS U54 MD007584NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

Although mother-to-child transmission of HIV has dramatically declined, the number of in utero HIV-exposed, uninfected infants is on the increase. HIV-exposed infants are at an increased risk of mortality, morbidity and slower early growth than their non-HIV exposed counterparts. Maternal HIV increases the risk of having preterm deliveries, intrauterine growth restriction and low birth weight babies. However, the mechanism underlying dysregulation of fetal growth in HIV-infected pregnant women is unknown. We sought to determine whether maternal HIV is associated with dysregulation of the insulin-like growth factor (IGF) axis, some angiogenic factors or other related biomarkers that regulate fetal growth. A total of 102 normotensive pregnant women were enrolled in a small cross-sectional study. Amongst these were thirty-one HIV-1 positive women receiving combination antiretroviral therapy (cART) (Mean age: 30.0 ± 5.1 years; % on ART: 83.9%; median plasma viral load: 683 copies/ml; median CD4 count: 350 cells/ul) and 71 HIV uninfected women (mean age: 27.3 ± 5.8) recruited at delivery. A panel of biomarkers including IGF1 and IGF binding proteins (IGFBP1, IGFBP3), angiopoietins (ANG) 1 and 2, matrix metalloproteinases (MMP) 2 and 9, and galectin 13, was measured in plasma collected from the placental intervillous space. The levels of IGF1, IGFBP1, ANG1, ANG2, MMP2, MMP9 and Gal-13 were not affected by maternal HIV, even when adjusted for maternal factors in linear regression models (all p>0.05). It was observed that HIV-infection in pregnancy did not significantly affect key markers of the IGF axis and angiogenic factors. If anything, it did not affect women. These findings highlight the importance of the use of ART during pregnancy, which maintains factors necessary for fetal development closer to those of healthy women. However, decrease in IGF1 levels might be exacerbated in women con-infected with HIV and malaria.

Indexed as

AdultAngiopoietinsAnti-Retroviral AgentsBiomarkersCameroonCross-Sectional StudiesFemaleHIV InfectionsHumansInsulin-Like Growth Factor Binding Protein 1Insulin-Like Growth Factor IMalariaMatrix Metalloproteinase 9PlacentaPregnancyYoung AdultAngiopoietinsAnti-Retroviral AgentsBiomarkersIGFBP1 protein, humanInsulin-Like Growth Factor Binding Protein 1Insulin-Like Growth Factor IMatrix Metalloproteinase 9

Identifiers

PMID31042729
PMCPMC6493724
OpenAlexW2943451461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.